New health-care payment models to lower the price of prescription drugs may be tested by the Health and Human Services Department under a Friday executive order from President Joe Biden.
The executive order aims to lower prescription drug costs across the US and follows landmark health-care legislation passed by Congress earlier this year that allows the HHS to negotiate drug prices with pharmaceutical companies.
Health and Human Services Secretary
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.